(Adnkronos) - CATANIA, Italy, May 2, 2023 /PRNewswire/ -- SIFI, a leading pharmaceutical company in the development of innovative solutions for the treatment of eye diseases, presented a series of scientific posters regarding preclinical and clinical research on its innovative product pipeline, during the ARVO annual meeting in New
Presentations included results from preclinical and clinical studies on XanterDES, a novel lubricating ophthalmic solution, intended to alleviate ocular discomfort in dry eye patients.
"Dry eye still represents a challenge, afflicting millions of people worldwide. SIFI is fully committed to finding innovative solutions towards treating and managing this disease." stated Maria Cristina Curatolo, SIFI Innovation and Medical Science Director. "XanterDES represents an important innovation in treating dry eye due to its unique formulation and we are pleased to have presented preclinical and clinical posters on this novel eye drop."
Following is a list of titles and authors:
Presentation Number - Posterboard Number: 672 - B0343
Session Title: Dry eye
Presentation Number - Posterboard Number: 3957 - B0274
Session Title: Dry eye (clinical)
Session Title: Dry eye (clinical)
XanterDES is a lubricating ophthalmic solution, intended to relieve discomfort and eye irritation due to environmental factors such as dust, heat, smoke, wind, air conditioning and allergens and is part of SIFI's well-known dry eye disease therapeutic portfolio. XanterDES is already available in Italy and in Romania and will be soon available in other markets as well.
SIFI is a leading international ophthalmic company, headquartered in Italy, focusing on eye care since 1935. SIFI develops, manufactures, and markets innovative therapeutic solutions for patients with ophthalmic conditions. SIFI is fully committed through its R&D to improving the quality of life of patients, exporting treatments to more than 40 countries worldwide with a direct presence in Italy, Spain, France, Romania, Mexico, and Turkey.
Contact: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo., +39 3336999669
View original content:https://www.prnewswire.co.uk/news-releases/sifi-presented-new-data-on-xanterdes-at-arvo-2023-301810916.html
